Navigation Links
New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer
Date:4/1/2009

death back to life," says PhRMA President and CEO Billy Tauzin. "The men and women working for America's pharmaceutical research companies are committed to developing new cancer medicines that, one day, could eradicate cancer all together."

Cancer medicines being developed include 122 for lung cancer, the leading cause of cancer death in the United States; 107 for breast cancer, which is expected to strike more than 180,000 American women this year; 70 for colorectal cancer, which is the third most common cancer in both men and women; and 103 for prostate cancer, which this year is expected to kill 28,000 American men. Additional medicines target brain cancer, kidney cancer, ovarian cancer, pancreatic cancer, skin cancer, and others.

The medicines represent many cutting-edge approaches, including a drug that delivers a synthetic version of a substance derived from scorpions directly to brain tumor cells; a number of cancer vaccines; medicines that target and kill specific cancer cells; and treatments that activate the patient's general immune system to destroy cancer.

"Researchers are making exciting progress in the search for new cures and treatments for cancer. But these efforts are wasted if the medicines we develop aren't accessible to patients who need them," said Johnson.

Help is available to patients in need through the Partnership for Prescription Assistance (PPA), a program sponsored by America's pharmaceutical research companies. To date, the PPA has helped more than 5.7 million patients nationwide, including more than 72,000 people in Colorado. Since its launch in April 2005, the PPA bus tour has visited all 50 states and more than 2,500 cities to educate people about patient assistance programs.

The "Help is Here Express" is staffed by trained specialists able to quickly help uninsured and financially struggling patients access information on more than 475 patient as
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
2. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
3. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
4. ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform
5. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
6. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
7. Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
8. Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis
9. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
10. ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimers Disease
11. New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)...  Span-America Medical Systems, Inc. (NASDAQ:  SPAN) announced ... second quarter results on Thursday, April 30, after the ... will conduct a conference call at 10:00 a.m. ... financial and operating results for the second quarter ended ... conference call will be available online at ...
(Date:4/24/2015)... 24, 2015 Research and Markets ... addition of the "Lab Accessories Market ... Reservoir/Valve/Tubing/Wash Station) & End User (OEM/Biotechnology & ... to 2020" report to their offering. ... is expected to reach $504.7 million by ...
(Date:4/24/2015)... 24, 2015 The National Institute of ... National Institutes of Health [NIH])  provided grants totaling ... for the development of diagnostic tests for antibiotic-resistant ... at U.S. health facilities , the NIAID and ... multiplexed and effective tests using alternative methods to ...
Breaking Medicine Technology:Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4
... Reportlinker.com announces that a new market ... , Reportlinker Adds Global Medical ... Sales Strategies and the Impact of Recession ... , Summary , "Global ...
... Corp. (TSX, FSE: HBP / OTCQX: HXBPF) today announced ... L-DOS47 product development programs following pre-investigational new drug ("pre-IND") ... , Helix requested the pre-IND meetings in order to ... filings with the FDA. The meeting on Topical Interferon ...
Cached Medicine Technology:Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 2Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 3Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 4Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 5Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 6Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 7Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 8Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 9Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 10Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 11Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 12Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 13Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 14Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 2Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 3Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 4Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 5Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 6Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 7Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 8
(Date:4/26/2015)... From March 18th, 2015 toward the middle of ... Trivedi, spent a month traveling in India to find ... the efforts of creating highly advanced, effective and less ... health care. , During their journey, they met ... lab facilities are approved by the U.S. Food and ...
(Date:4/26/2015)... St. Petersburg, FL (PRWEB) April 26, 2015 ... San Diego, California. The city is one which is synonymous ... sites. Tourism, international trade, and education are major economic influencers ... States. Producers of the dynamic talk show are pleased to ... 4 on Sunday, April 26 at 3:00 PM PDT. Tune ...
(Date:4/25/2015)... Avid Collector Andrew Hawley from Vintage ... Greensboro Coliseum concert posters. The concert was held on ... Second American Tour. , According to Hawley, “The ... Baltimore, Maryland. This poster blank was used to advertise ... Globe uses garish lettering and colors on this boxing ...
(Date:4/25/2015)... Carinsurancequotesinfo.com has released a new blog post that explains ... for flatbed trucks. , Flatbed trucks are used ... are mainly used for commercial purposes and thus require ... that by comparing multiple offers, drivers can find low ... , It is now possible to compare free online ...
(Date:4/25/2015)... April 25, 2015 Parker and Sons projects ... cooling, has spiked in Arizona alongside the growing economy. As ... forty employees for April to help account for the rising ... employees in April is something we are enthusiastic about. It ... Paul Kelly, president at Parker and Sons. , Indeed, Parker ...
Breaking Medicine News(10 mins):Health News:Trivedi Science™ Has Started Scientific Research to Create More Effective Pharmaceuticals and Nutraceuticals 2Health News:Trivedi Science™ Has Started Scientific Research to Create More Effective Pharmaceuticals and Nutraceuticals 3Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2Health News:Parker and Sons Plans to Expand in 2015 2
... Company Locations in Alabama, Georgia, Indiana, Iowa, Kansas, ... Texas, Virginia and WisconsinWASHINGTON, Jan. 15 SouthernCare ... the United States a total of $24.7 million ... submitted false claims to the government for patients ...
... coalition of clergy and lay members from faith organizations throughout ... Senator Richard Burr to end his opposition to legislation that ... over tobacco products. The legislation would protect kids from ... to filibuster the legislation if it was brought to the ...
... required for foods from these animals, agency says , , ... and Drug Administration on Thursday issued its final regulations ... rules do not require consumer labeling for foods from ... (rDNA) to introduce new characteristics or traits into an ...
... 15 Boston Scientific Corporation (NYSE: BSX ) today ... Circuit. The case involves a Boston Scientific patent, which in ... the decision, the Court found that the patent was invalid as ... by Johnson and Johnson of a 2005 jury verdict in the ...
... of Trade Alerts on stocks making news today. Investors can ... visiting: http://www.BeaconEquity.com/m Today,s Trade Alerts include: Eli Lily ... (NYSE: PCS ), ConAgra Foods Inc. (NYSE: ... ), Target Corp. (NYSE: TGT ) and Dow ...
... around 50 percent, despite proven benefits, report says , , THURSDAY, ... colon cancer saves lives, but too few Americans are getting ... report shows. , The rate of screening for breast and ... the rate of colorectal cancer screening has increased but not ...
Cached Medicine News:Health News:Alabama-Based Hospice Company Pays U.S. $24.7 Million to Settle Health Care Fraud Claims 2Health News:North Carolina Faith Leaders Call on Sen. Burr to End Filibuster Threat of Legislation to Protect Kids From Tobacco 2Health News:North Carolina Faith Leaders Call on Sen. Burr to End Filibuster Threat of Legislation to Protect Kids From Tobacco 3Health News:FDA Issues Final Regulations for Genetically Engineered Animals 2Health News:FDA Issues Final Regulations for Genetically Engineered Animals 3Health News:Boston Scientific Announces Court Decision 2Health News:Boston Scientific Announces Court Decision 3Health News:Beacon Equity Issues Technical Trade Alerts on Headline Stocks: LLY, PCS, CAG, FRX, TGT, DOW 2Health News:More Americans Urged to Get Cancer Screenings 2Health News:More Americans Urged to Get Cancer Screenings 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: